These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 23022428)

  • 1. Antiplatelet therapy to prevent hemodialysis vascular access failure: systematic review and meta-analysis.
    Palmer SC; Di Micco L; Razavian M; Craig JC; Ravani P; Perkovic V; Tognoni G; Graziano G; Jardine M; Pellegrini F; Nicolucci A; Webster A; Strippoli GF
    Am J Kidney Dis; 2013 Jan; 61(1):112-22. PubMed ID: 23022428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 Polyunsaturated Fatty Acid Supplementation to Prevent Arteriovenous Fistula and Graft Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Viecelli AK; Irish AB; Polkinghorne KR; Hawley CM; Johnson DW; Mori TA; Pascoe EM; Strippoli GFM; Lok CE; Palmer SC
    Am J Kidney Dis; 2018 Jul; 72(1):50-61. PubMed ID: 29395485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenesis of hemodialysis vascular access failure and systemic therapies for its prevention: Optimism unfulfilled.
    Viecelli AK; Mori TA; Roy-Chaudhury P; Polkinghorne KR; Hawley CM; Johnson DW; Pascoe EM; Irish AB
    Semin Dial; 2018 May; 31(3):244-257. PubMed ID: 29178510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial.
    Dember LM; Beck GJ; Allon M; Delmez JA; Dixon BS; Greenberg A; Himmelfarb J; Vazquez MA; Gassman JJ; Greene T; Radeva MK; Braden GL; Ikizler TA; Rocco MV; Davidson IJ; Kaufman JS; Meyers CM; Kusek JW; Feldman HI;
    JAMA; 2008 May; 299(18):2164-71. PubMed ID: 18477783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing arteriovenous shunt failure in hemodialysis patients: a population-based cohort study.
    Fan PY; Lee CC; Liu SH; Li IJ; Weng CH; Tu KH; Hsieh MY; Kuo CF; Chang TY; Tian YC; Yang CW; Wu HH
    J Thromb Haemost; 2019 Jan; 17(1):77-87. PubMed ID: 30472783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Fish Oil Supplementation and Aspirin Use on Arteriovenous Fistula Failure in Patients Requiring Hemodialysis: A Randomized Clinical Trial.
    Irish AB; Viecelli AK; Hawley CM; Hooi LS; Pascoe EM; Paul-Brent PA; Badve SV; Mori TA; Cass A; Kerr PG; Voss D; Ong LM; Polkinghorne KR;
    JAMA Intern Med; 2017 Feb; 177(2):184-193. PubMed ID: 28055065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preemptive Correction of Arteriovenous Access Stenosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Ravani P; Quinn RR; Oliver MJ; Karsanji DJ; James MT; MacRae JM; Palmer SC; Strippoli GF
    Am J Kidney Dis; 2016 Mar; 67(3):446-60. PubMed ID: 26776537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular Access Outcomes Reported in Maintenance Hemodialysis Trials: A Systematic Review.
    Viecelli AK; O'Lone E; Sautenet B; Craig JC; Tong A; Chemla E; Hooi LS; Lee T; Lok C; Polkinghorne KR; Quinn RR; Vachharajani T; Vanholder R; Zuo L; Irish AB; Mori TA; Pascoe EM; Johnson DW; Hawley CM
    Am J Kidney Dis; 2018 Mar; 71(3):382-391. PubMed ID: 29203125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin receptor blockers and antiplatelet agents are associated with improved primary patency after arteriovenous hemodialysis access placement.
    Jackson RS; Sidawy AN; Amdur RL; Khetarpal A; Macsata RA
    J Vasc Surg; 2011 Dec; 54(6):1706-12. PubMed ID: 21840155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical Adjuvant Therapy in Reducing Thrombosis With Arteriovenous Grafts and Fistulae Use: A Meta-Analysis of Randomized Controlled Trials.
    Ullah K; Bashir M; Ain NU; Sarfraz A; Sarfraz Z; Sarfraz M; Cherrez-Ojeda I
    Clin Appl Thromb Hemost; 2021; 27():10760296211063882. PubMed ID: 34873965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular access outcomes and medication use: a USRDS study.
    Yevzlin AS; Conley EL; Sanchez RJ; Young HN; Becker BN
    Semin Dial; 2006; 19(6):535-9. PubMed ID: 17150056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antiplatelet therapy on cardiovascular and kidney outcomes in patients with chronic kidney disease: a systematic review and meta-analysis.
    Su X; Yan B; Wang L; Lv J; Cheng H; Chen Y
    BMC Nephrol; 2019 Aug; 20(1):309. PubMed ID: 31390997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts.
    Osborn G; Escofet X; Da Silva A
    Cochrane Database Syst Rev; 2008 Oct; (4):CD002786. PubMed ID: 18843633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Saran R; Dykstra DM; Wolfe RA; Gillespie B; Held PJ; Young EW;
    Am J Kidney Dis; 2002 Dec; 40(6):1255-63. PubMed ID: 12460045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet medications in hemodialysis patients: a systematic review of bleeding rates.
    Hiremath S; Holden RM; Fergusson D; Zimmerman DL
    Clin J Am Soc Nephrol; 2009 Aug; 4(8):1347-55. PubMed ID: 19578002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of beraprost sodium in maintaining vascular access patency in patients on hemodialysis.
    Kim M; Kim JU; Kim SM; Kim H
    Int Urol Nephrol; 2017 Jul; 49(7):1287-1295. PubMed ID: 28409403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial.
    Lok CE; Moist L; Hemmelgarn BR; Tonelli M; Vazquez MA; Dorval M; Oliver M; Donnelly S; Allon M; Stanley K;
    JAMA; 2012 May; 307(17):1809-16. PubMed ID: 22550196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis Trial.
    Dember LM; Kaufman JS; Beck GJ; Dixon BS; Gassman JJ; Greene T; Himmelfarb J; Hunsicker LG; Kusek JW; Lawson JH; Middleton JP; Radeva M; Schwab SJ; Whiting JF; Feldman HI;
    Clin Trials; 2005; 2(5):413-22. PubMed ID: 16317810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts.
    Da Silva AF; Escofet X; Rutherford PA
    Cochrane Database Syst Rev; 2003; (2):CD002786. PubMed ID: 12804437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis.
    Kaufman JS; O'Connor TZ; Zhang JH; Cronin RE; Fiore LD; Ganz MB; Goldfarb DS; Peduzzi PN;
    J Am Soc Nephrol; 2003 Sep; 14(9):2313-21. PubMed ID: 12937308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.